Feiba VH

Drug List

Feiba VH

Drug Name

Feiba VH (Anti-Inhibitor Coagulant Complex)

Manufactured By

Baxter Healthcare Corporation

Drug Savings


Nationwide Prescription Connection (NPC) is an experienced advocacy service that helps connect patients to manufacturer provided free and discount programs. We can help the uninsured, under insured, those in the Medicare gap also known as the "doughnut hole", or even those needing help with expensive co-pays.  Our web site makes it easy for you to enter the medications you are taking, along with some basic patient information, and then finds the program that is right for you.


NPC's mission is your health. We recognize your need for help when you are applying for discount programs for your prescription medications. We consist of friendly and experienced advocates that not only know how these free and discount programs work, but are ready to help. We are available to take your call and answer any questions you may have as you search for the right program to fit your needs. We can also explain any supporting material you may need to provide as you apply for these programs. If for any reason you are denied, we also are experienced in the best appeals process with a high success rate.

Treats Disease/Condition

Uses

Control and prevention of bleeding episodes Use around the time of surgery Routine prophylaxis to prevent or reduce the frequency of bleeding episodes. FEIBA is not indicated for the treatment of bleeding episodes resulting from coagulation factor deficiencies in the absence of inhibitors to coagulation factor VIII or coagulant factor IX.

How To Use

Anti-inhibitor coagulant complex is injected into a vein through an IV. You may be shown how to use an IV at home. Do not self-inject this medicine if you do not fully understand how to give the injection and properly dispose of used needles, IV tubing, and other items used to inject the medicine. Anti-inhibitor coagulant complex is usually given once every 6 to 12 hours until your condition improves.

Side Effects

You should not use FEIBA if: You had a previous severe allergic reaction to the product (reactions causing discomforts that are damaging and life threatening) You have signs of development of small blood vessel clots throughout the body You have sudden blood vessel clots or blocked blood vessels, (e.g., heart attack or stroke) Events involving blood clots blocking blood vessels can occur with FEIBA, particularly after receiving high doses and/or in patients with risk factors for clotting. Infusion of FEIBA should not exceed a dose of 100 units per kg body weight every 6 hours and daily doses of 200 units per kg of body weight. Maximum injection or infusion rate must not exceed 2 units per kg of body weight per minute. At first sign or symptom of a sudden blood vessel clot or blocked blood vessel (e.g., chest pain or pressure, shortness of breath, altered consciousness, vision, or speech, limb or abdomen swelling and/or pain), stop FEIBA administration promptly and seek emergency medical treatment. Allergic-type hypersensitivity reactions, including severe, sometimes fatal allergic reactions that can involve the whole body, can occur following the infusion of FEIBA. Call your doctor or get emergency treatment right away if you get a rash, hives or welts, experience itching, tightness of the throat, vomiting, abdominal pain, chest pain or tightness, difficulty breathing, lightheadedness, dizziness, nausea or fainting. Because FEIBA is made from human plasma it may carry a risk of transmitting infectious agents, e.g., viruses, the variant Creutzfeldt-Jakob disease (vCJD) agent and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent. The most frequent side effects observed during the prophylaxis trial were anemia, diarrhea, bleeding into a joint, signs of hepatitis B surface antibodies, nausea, and vomiting. The serious side effects seen with FEIBA are allergic reactions and clotting events involving blockage of blood vessels, which include stroke, blockage of the main blood vessel to the lung, and deep vein

Drug Interactions

Activase IV (alteplase iv) Alphanine Heat-Treat/Solv Susp IV (coagulation factor ix iv) Alphanine Sd Heat Treat/Solv IV (coagulation factor ix iv) AlphaNine SD IV (coagulation factor ix iv) alteplase inj alteplase iv Angiomax IV (bivalirudin iv) anti-inhibitor coagulant cmplx iv apixaban oral argatroban iv Autoplex T IV (anti-inhibitor coagulant cmplx iv)

In Case of Overdose

: If overdose is suspected, contact a poison control center or emergency room immediately.

In Case of Missed Dose

MISSED DOSE: Consult your pharmacist

Storage

You may store this medicine at room temperature for up to 6 months or until the expiration date on the label.